D L Segev Selected Research

D L Segev Research Topics

Disease

6	Chronic Kidney Failure (Chronic Renal Failure) 12/2017 - 09/2010
6	Infections 12/2017 - 03/2009
5	Delayed Graft Function 02/2016 - 01/2007
5	Neoplasms (Cancer) 01/2015 - 09/2000
4	Death (Near-Death Experience) 02/2017 - 07/2007
3	Thrombosis (Thrombus) 02/2014 - 04/2007
3	End Stage Liver Disease 01/2014 - 12/2012
2	Hepatitis C 10/2018 - 05/2010
2	Renal Insufficiency (Renal Failure) 02/2017 - 03/2009
2	Obesity 02/2017 - 01/2016
2	Frailty 01/2015 - 08/2013
2	Prostatic Neoplasms (Prostate Cancer) 01/2015 - 03/2013
2	Acquired Immunodeficiency Syndrome (AIDS) 06/2011 - 03/2009
2	Ovarian Neoplasms (Ovarian Cancer) 03/2001 - 11/2000
2	COVID-19 related adult multisystem inflammatory disease 11/2000 - 09/2000
1	Ischemia 02/2016
1	HIV Infections (HIV Infection) 01/2016
1	Anemia 01/2016
1	Hemorrhage 01/2016
1	Wounds and Injuries (Trauma) 01/2016
1	Opportunistic Infections (Opportunistic Infection) 08/2015
1	Chronic Renal Insufficiency 04/2015
1	Brain Death (Brain Dead) 01/2015
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 02/2014
1	Vascular System Injuries 02/2014
1	Hepatitis B 06/2013
1	Kidney Neoplasms (Kidney Cancer) 03/2013
1	Cytomegalovirus Infections (Inclusion Disease) 12/2012
1	Pre-Eclampsia (Preeclampsia) 11/2011
1	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2011
1	Liver Failure 04/2011
1	Postoperative Pain 06/2010
1	Convalescence 06/2010
1	Liver Diseases (Liver Disease) 04/2010
1	Heart Arrest (Cardiac Arrest) 06/2008
1	Body Weight (Weight, Body) 06/2008
1	Necrosis 04/2007
1	Fibroadenoma 09/2000
1	Breast Neoplasms (Breast Cancer) 09/2000
1	Adenocarcinoma 09/2000

Drug/Important Bio-Agent (IBA)

3	CreatinineIBA 02/2017 - 01/2007
3	dicarboxydine (DCD)IBA 01/2015 - 07/2007
3	N-acetyltalosaminuronic acid (NAT)IBA 06/2011 - 03/2009
2	Nucleic AcidsIBA 06/2013 - 03/2009
2	serum P-component (CIt)IBA 06/2008 - 01/2007
2	Transforming Growth Factor beta (TGF-beta)IBA 11/2000 - 09/2000
1	Antiviral Agents (Antivirals)IBA 10/2018
1	Dihydrotachysterol (AT 10)IBA 12/2016
1	insulin receptor-related receptor (IRR)IBA 12/2016
1	IceIBA 02/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Sirolimus (Rapamycin)FDA Link 01/2015
1	Antiphospholipid AntibodiesIBA 02/2014
1	eculizumab FDA Link 02/2014
1	Complement Inactivating AgentsIBA 02/2014
1	RNA (Ribonucleic Acid)IBA 06/2011
1	Calcineurin InhibitorsIBA 03/2009
1	Histidine (L-Histidine)FDA Link 02/2009
1	Tryptophan (L-Tryptophan)FDA Link 02/2009
1	Intravenous Immunoglobulins (IVIG)FDA Link 04/2007
1	Capsules (Microcapsules)IBA 03/2001
1	PolymersIBA 03/2001
1	Recombinant ProteinsIBA 03/2001
1	Hormones (Hormone)IBA 11/2000
1	LigandsIBA 09/2000
1	Anti-Mullerian HormoneIBA 09/2000
1	Estrogen ReceptorsIBA 09/2000
1	anti-Mullerian hormone receptorIBA 09/2000

Therapy/Procedure

9	Kidney Transplantation 12/2017 - 03/2009
8	Transplantation 12/2016 - 01/2007
5	Liver Transplantation 01/2014 - 04/2010
2	Patient Readmission 01/2015 - 08/2013
1	Art Therapy 12/2017
1	Warm Ischemia 02/2016
1	Anesthesia 01/2016
1	Nephrectomy 01/2016
1	Cesarean Section (Caesarean Section) 11/2011
1	Renal Dialysis (Hemodialysis) 09/2010
1	Length of Stay 06/2010
1	Plasmapheresis 04/2007